Edwards v Meril: Behind the UPC’s landmark medtech showdown

As Edwards secures another win against its rival, LSIPR talks to Siddharth Kusumakar—partner at Powell Gilbert and counsel for the winning party.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

Edwards v Meril: 3 insights from the UPC Court of Appeal’s decision

19 December 2025 With its landmark ruling, the court has delivered guidance for patentees and litigants— including three takeaways for counsel and rights holders, explain Tobias Wuttke and Axel Berger of Bardehle Pagenberg.

Europe

Diagnosis: What’s holding back UK life sciences?

15 December 2025 The country aims to become the world’s third-largest life sciences economy by 2035, but stalled investments, regulatory hurdles, and talent shortages are raising questions about whether the target is achievable, finds Marisa Woutersen.

Europe

UPC appeals court hands Amgen a win in cholesterol dispute

27 November 2025 The Court of Appeal has overturned a ruling that revoked the pharma company’s cholesterol-lowering antibody patent, clarifying key principles for assessing inventive step.

More features

5 ways the USPTO director is changing US innovation

EU unveils sweeping pharma, biotech, and medical device reforms

Mirum targets generics in quartet of suits over liver treatment

Hogan Lovells and Cadwalader strike historic deal to create $3.6bn firm

WATCH: Clinical trials and their impact on patentability in Europe

Edwards v Meril: 3 insights from the UPC Court of Appeal’s decision

Abbott wins appeal to restore glucose monitoring patent

Regeneron v Alvotech: The big impact

Edwards v Meril: Behind the UPC’s landmark medtech showdown

More on this story

Editor's picks

Editor's picks

More features